AbbVie Unveils New Durable Risankizumab Data In Psoriatic Arthritis
Pfizer's Arthritis Drug Wins European Approval In Pediatric & Adult Patients
FDA To Miss Action Dates For AbbVie's Upadacitinib Application For Psoriatic Arthritis, Ankylosing Spondylitis
FDA Gives Emergency Use Nod For Roche's Arthritis Drug Against Severe COVID-19
Arthritis Recent News
Novartis's Late-stage Study On Cosentyx Hits Primary Endpoint Goal In Juvenile Idiopathic Arthritis
Supreme Court Rebuffs Novartis Appeal Over Amgen's Arthritis Drug Enbrel: Report
Analysts React To FDA AdCom Vote On ChemoCentryx's Avacopan, Stock Plunges
AbbVie Files US, Europe Applications For Skyrizi In Psoriatic Arthritis
Pfizer's Xeljanz Under Health Canada's Scrutiny For Safety Risks
AbbVie Shares Drop As Review For Upadacitinib US Application In Psoriatic Arthritis Pushed Back For Three Months
Provention Bio's CEO On Identifying Autoimmune Diseases 'Before It's Too Late'
Arthritis Sufferers Lead The Way For Advancing Cannabis As Pain Medicine
Video: Using Cannabis To Treat Arthritis, Explained For Beginners